Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Hepatology

Symptoms and Look-Alikes: Sorting Out the Puzzle

At a Glance

Autoimmune hepatitis (AIH) can be difficult to diagnose because its symptoms—like profound fatigue, joint pain, and jaundice—often mimic other conditions. Doctors use blood tests, biopsies, and steroid trials to rule out look-alikes like viral hepatitis or drug-induced liver injury.

Diagnosing Autoimmune Hepatitis (AIH) can be a complex puzzle because it rarely looks the same in two different people. Some patients have no symptoms and only discover they have a liver issue during a routine blood test [1][2]. While a small number of patients may experience a sudden, severe illness known as acute liver failure (ALF), this presentation is less common [3][4]. Most people experience a slower, chronic onset.

The Many Faces of AIH

Because the symptoms of AIH are “non-specific” (meaning they can be caused by many different things), they are often mistaken for other conditions. Common symptoms include:

  • Fatigue: A deep, persistent exhaustion that doesn’t go away with rest.
  • Jaundice: A yellowing of the skin or the whites of the eyes [5].
  • Abdominal Discomfort: Often felt as a dull ache in the upper right side where the liver is located.
  • Joint Pain: A common sign that the immune system is overactive throughout the body.

What Does a “Flare” Feel Like?

Because AIH is often silent, your doctor will rely heavily on blood tests to monitor disease activity. However, if your AIH “flares” (becomes highly active again), you may notice physical symptoms returning. A flare might feel like a sudden return of profound fatigue, new joint pain, nausea, or a recurrence of jaundice.

The “Look-Alike” Challenge

Doctors must rule out several other conditions that mimic AIH before they can be certain of the diagnosis. This process is called differential diagnosis [6].

  • Drug-Induced Liver Injury (DILI): This is one of the hardest conditions to distinguish from AIH. Certain medications (like nitrofurantoin or minocycline) and herbal supplements can trigger an immune attack that looks exactly like AIH on a biopsy [7][8]. The main difference is that DILI often resolves once the drug is stopped, whereas AIH is a chronic condition [9][10].
  • Viral Hepatitis: Infections like Hepatitis A, B, C, or E can cause similar liver inflammation. Doctors use viral blood panels to ensure an infection isn’t the primary cause [6][11].
  • Metabolic Liver Disease (NAFLD/MASLD): Fatty liver disease can also cause elevated liver enzymes, though the underlying cause is metabolic rather than autoimmune.

When Tests are Negative: Seronegative AIH

In most cases of AIH, blood tests show “autoantibodies” like ANA or SMA. However, about 10% to 20% of patients have seronegative AIH, meaning these standard antibody tests come back negative [12][13]. These patients often present with more sudden, acute symptoms [3]. In these cases, doctors rely heavily on:

  1. Elevated IgG levels: High levels of Immunoglobulin G (a type of antibody) in the blood [12][14].
  2. Liver Biopsy: Looking for specific patterns of damage, such as interface hepatitis (inflammation where the liver cells meet the connective tissue) [3][15].
  3. Treatment Response: If a patient improves quickly after taking corticosteroids, it strongly suggests the cause was autoimmune [3][16].

Overlap Syndromes

Sometimes, a patient doesn’t just have AIH—they have features of two different autoimmune liver diseases at once. This is called an overlap syndrome [17].

  • AIH-PBC Overlap: Features of both AIH and Primary Biliary Cholangitis (which affects the small bile ducts) [18].
  • AIH-PSC Overlap: Features of both AIH and Primary Sclerosing Cholangitis (which affects the larger bile ducts) [19].

These overlap cases can be more aggressive and may require a combination of different medications to manage both aspects of the disease [18][20].

Common questions in this guide

What does an autoimmune hepatitis flare feel like?
An AIH flare can feel like a sudden return of intense fatigue, new joint pain, nausea, or a recurrence of jaundice. It indicates that the disease has become highly active again and you should contact your doctor.
How is drug-induced liver injury (DILI) different from autoimmune hepatitis?
DILI is triggered by specific medications or herbal supplements and usually resolves once the drug is stopped. In contrast, AIH is a lifelong chronic condition. Doctors must carefully review your medication history because the two conditions look identical on a liver biopsy.
What does seronegative autoimmune hepatitis mean?
Seronegative AIH means that your standard autoantibody blood tests (like ANA or SMA) come back negative, which happens in up to 20% of patients. In these cases, doctors rely on elevated IgG levels, liver biopsies, and your response to steroid treatments to confirm the diagnosis.
What is an autoimmune hepatitis overlap syndrome?
An overlap syndrome occurs when a patient has features of both autoimmune hepatitis and another autoimmune liver disease at the same time. The most common overlaps are with Primary Biliary Cholangitis (PBC) or Primary Sclerosing Cholangitis (PSC), which affect the bile ducts.
Can vitamins or herbal supplements cause autoimmune hepatitis?
While supplements don't cause AIH, certain vitamins, medications, and herbal supplements can trigger a condition called Drug-Induced Liver Injury (DILI). This condition causes liver inflammation that looks exactly like AIH, making it crucial to tell your doctor about everything you take.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my lab results, what specific 'look-alike' conditions like DILI or viral hepatitis have you already ruled out?
  2. 2.If my antibody tests (ANA/SMA) came back negative, what other evidence points toward AIH rather than another condition?
  3. 3.Does my case show any signs of an 'overlap syndrome' with PBC or PSC?
  4. 4.Could any of the medications, vitamins, or supplements I’ve taken recently be causing a drug-induced version of this inflammation?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    A Case Report of Sjögren's Syndrome Presenting With Autoimmune Hepatitis.

    Caretti R, Wojtas C, Baniasadi M, et al.

    Cureus 2022; (14(3)):e23464 doi:10.7759/cureus.23464.

    PMID: 35494911
  2. 2

    Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients.

    Nguyen Canh H, Harada K, Ouchi H, et al.

    Journal of clinical pathology 2017; (70(11)):961-969 doi:10.1136/jclinpath-2016-204271.

    PMID: 28428284
  3. 3

    Seronegative autoimmune hepatitis in children: a single-center experience.

    Islek A, Keskin H

    Acta gastro-enterologica Belgica 2021; (84(2)):305-310 doi:10.51821/84.2.305.

    PMID: 34217180
  4. 4

    Autoimmune hepatitis in India: single tertiary referral centre experience.

    Amarapurkar D, Dharod M, Amarapurkar A

    Tropical gastroenterology : official journal of the Digestive Diseases Foundation 2015; (36(1)):36-45 doi:10.7869/tg.243.

    PMID: 26591953
  5. 5

    Retrospective, single-center analysis of autoimmune hepatitis in Jordanian children: clinical features, treatments, and outcomes.

    Altamimi E, Al Omari D, Obeidat H, Barham K

    BMC pediatrics 2024; (24(1)):102 doi:10.1186/s12887-024-04590-9.

    PMID: 38331749
  6. 6

    Autoimmune Hepatitis, Sclerosing Cholangitis, and Autoimmune Sclerosing Cholangitis or Overlap Syndrome.

    Kerkar N, Chan A

    Clinics in liver disease 2018; (22(4)):689-702 doi:10.1016/j.cld.2018.06.005.

    PMID: 30266157
  7. 7

    [Drug-induced autoimmune-like liver injury].

    Weber S

    Innere Medizin (Heidelberg, Germany) 2024; (65(4)):334-339 doi:10.1007/s00108-024-01669-4.

    PMID: 38374310
  8. 8

    Differential characteristics in drug-induced autoimmune hepatitis.

    Martínez-Casas OY, Díaz-Ramírez GS, Marín-Zuluaga JI, et al.

    JGH open : an open access journal of gastroenterology and hepatology 2018; (2(3)):97-104 doi:10.1002/jgh3.12054.

    PMID: 30483571
  9. 9

    Drug-induced autoimmune hepatitis: A minireview.

    Tan CK, Ho D, Wang LM, Kumar R

    World journal of gastroenterology 2022; (28(24)):2654-2666 doi:10.3748/wjg.v28.i24.2654.

    PMID: 35979160
  10. 10

    Autoimmune-like chronic hepatitis induced by olmesartan.

    Barge S, Ziol M, Nault JC

    Hepatology (Baltimore, Md.) 2017; (66(6)):2086-2088 doi:10.1002/hep.29228.

    PMID: 28437842
  11. 11

    Development and validation of a noninvasive prediction model of autoimmune hepatitis in patients with liver diseases.

    Wang L, Hu YF, Yang AY, et al.

    Scandinavian journal of gastroenterology 2024; (59(1)):62-69 doi:10.1080/00365521.2023.2249571.

    PMID: 37649307
  12. 12

    Seronegative Autoimmune Hepatitis.

    Bhumi SA, Wu GY

    Journal of clinical and translational hepatology 2023; (11(2)):459-465 doi:10.14218/JCTH.2022.00235.

    PMID: 36643052
  13. 13

    The clinical phenotypes of autoimmune hepatitis: A comprehensive review.

    Wang Q, Yang F, Miao Q, et al.

    Journal of autoimmunity 2016; (66()):98-107.

    PMID: 26614611
  14. 14

    Seronegative Autoimmune Hepatitis A Clinically Challenging Difficult Diagnosis.

    Sherigar JM, Yavgeniy A, Guss D, et al.

    Case reports in medicine 2017; (2017()):3516234 doi:10.1155/2017/3516234.

    PMID: 28761444
  15. 15

    Autoimmune post-infantile giant cell hepatitis: a case report and review of the literature.

    Xiao Y, Gao ZH, Deschenes M

    Canadian liver journal 2021; (4(2)):104-109 doi:10.3138/canlivj-2020-0024.

    PMID: 35991767
  16. 16

    Seronegative autoimmune hepatitis in children: Spectrum of disorders.

    Maggiore G, Socie G, Sciveres M, et al.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2016; (48(7)):785-91.

    PMID: 27079745
  17. 17

    Autoimmune hepatitis - primary biliary cholangitis overlap syndrome. Long-term outcomes of a retrospective cohort in a university hospital.

    Martínez Casas OY, Díaz Ramírez GS, Marín Zuluaga JI, et al.

    Gastroenterologia y hepatologia 2018; (41(9)):544-552 doi:10.1016/j.gastrohep.2018.05.019.

    PMID: 30017212
  18. 18

    Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes.

    Park Y, Cho Y, Cho EJ, Kim YJ

    Clinical and molecular hepatology 2015; (21(2)):150-7 doi:10.3350/cmh.2015.21.2.150.

    PMID: 26157752
  19. 19

    Fulminant Primary Biliary Cholangitis-Autoimmune Hepatitis (PBC-AIH) Overlap Syndrome in a 27-Year-Old Woman With Childhood-Onset AIH: Steroid-Refractory Decompensation Necessitating Urgent Transplant Evaluation.

    Said E, Tafesse Y, Elbenawi HR, et al.

    Cureus 2025; (17(7)):e87519 doi:10.7759/cureus.87519.

    PMID: 40786261
  20. 20

    Triple autoimmune overlap syndrome of the liver: a rare case of concomitant PBC, PSC, and AIH.

    Hassen H, Dahmani W, Bedoui G, et al.

    Future science OA 2025; (11(1)):2601633 doi:10.1080/20565623.2025.2601633.

    PMID: 41355485

This page is for informational purposes only and does not replace professional medical advice. Always consult your hepatologist or primary care provider about your specific symptoms, diagnosis, and treatment plan.

Get notified when new evidence is published on Autoimmune hepatitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.